Most With Medicare Don’t Compare Plan Options During Open Enrollment
Springfield, Ohio: How Candidates Amplify Misinformation
In his latest column, KFF President and CEO Drew Altman explains the impact of misinformation about immigrants, examining the challenges of correcting misinformation shared by candidates or potentially amplifying it.
Misinformation About Immigrants in the 2024 Election
Latest News
-
KFF Health News' 'What the Health?': Congress Punts to a Looming Lame-Duck Session
-
In Montana Senate Race, Democrat Jon Tester Misleads on Republican Tim Sheehy’s Abortion Stance
-
Nursing Aides Plagued by PTSD After ‘Nightmare’ Covid Conditions, With Little Help
-
Watch: What You Reveal, You Heal — Meeting the Makers of ‘Silence in Sikeston’
-
Over 57 Million Could Be Clinically Eligible for GLP-1 Drugs
Over two in five (57.4 million) adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues.
-
Virtual Event: What the 2024 Election Could Mean for Health Care
Join KFF for our next Health Wonk Shop at noon ET on Tuesday, October 1. KFF’s Larry Levitt and two veteran health policy advisors will discuss what the presidential election will mean for health coverage, affordability, and the federal budget.
-
Examining Recent Trends in Opioid Overdose Deaths
Our analysis examines the recent decline in opioid overdose deaths during the latter half of 2023, with a focus on how trends vary by age, race, gender and state. The last six months of 2023 saw declines in opioid deaths nationally and in three quarters of states vs. the same months in 2022.
-
Beyond the Data by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.